Stay updated with breaking news from Quantamental Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell Protagonist Therapeutics Stock? Get The Latest PTGX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Guggenheim upgraded shares of Accolade (NASDAQ:ACCD – Get Rating) from a neutral rating to a buy rating in a report released on Thursday, MarketBeat reports. The brokerage currently has $16.00 price target on the stock. Other research analysts have also issued research reports about the company. Raymond James started coverage on Accolade in a report […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has received an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that […]
StockNews.com upgraded shares of Macerich (NYSE:MAC – Get Rating) from a sell rating to a hold rating in a research report report published on Friday morning. MAC has been the topic of several other research reports. Piper Sandler upped their price target on Macerich from $9.00 to $11.00 and gave the company an underweight rating […]
Clean Energy Fuels Corp. (NASDAQ:CLNE – Get Rating) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have issued a buy recommendation on the […]